Siemens Helge, Jackstadt Rene, Kaller Markus, Hermeking Heiko
Experimental and Molecular Pathology, Institute of Pathology, Ludwig-Maximilians-University München, D-80337 Munich, Germany.
Oncotarget. 2013 Sep;4(9):1399-415. doi: 10.18632/oncotarget.1202.
The c-Kit receptor tyrosine kinase is commonly over-expressed in different types of cancer. p53 activation is known to result in the down-regulation of c-Kit. However, the underlying mechanism has remained unknown. Here, we show that the p53-induced miR-34 microRNA family mediates repression of c-Kit by p53 via a conserved seed-matching sequence in the c-Kit 3'-UTR. Ectopic miR-34a resulted in a decrease in Erk signaling and transformation, which was dependent on the down-regulation of c-Kit expression. Furthermore, ectopic expression of c-Kit conferred resistance of colorectal cancer (CRC) cells to treatment with 5-fluorouracil (5-FU), whereas ectopic miR-34a sensitized the cells to 5-FU. After stimulation with c-Kit ligand/stem cell factor (SCF) Colo320 CRC cells displayed increased migration/invasion, whereas ectopic miR-34a inhibited SCF-induced migration/invasion. Activation of a conditional c-Kit allele induced several stemness markers in DLD-1 CRC cells. In primary CRC samples elevated c-Kit expression also showed a positive correlation with markers of stemness, such as Lgr5, CD44, OLFM4, BMI-1 and β-catenin. On the contrary, activation of a conditional miR-34a allele in DLD-1 cells diminished the expression of c-Kit and several stemness markers (CD44, Lgr5 and BMI-1) and suppressed sphere formation. MiR-34a also suppressed enhanced sphere-formation after exposure to SCF. Taken together, our data establish c-Kit as a new direct target of miR-34 and demonstrate that this regulation interferes with several c-Kit-mediated effects on cancer cells. Therefore, this regulation may be potentially relevant for future diagnostic and therapeutic approaches.
c-Kit受体酪氨酸激酶在不同类型的癌症中通常过度表达。已知p53激活会导致c-Kit的下调。然而,其潜在机制仍不清楚。在此,我们表明p53诱导的miR-34微小RNA家族通过c-Kit 3'-UTR中的保守种子匹配序列介导p53对c-Kit的抑制。异位表达miR-34a导致Erk信号传导和细胞转化减少,这依赖于c-Kit表达的下调。此外,c-Kit的异位表达赋予结肠直肠癌(CRC)细胞对5-氟尿嘧啶(5-FU)治疗的抗性,而异位表达miR-34a使细胞对5-FU敏感。用c-Kit配体/干细胞因子(SCF)刺激后,Colo320 CRC细胞的迁移/侵袭增加,而异位表达miR-34a抑制SCF诱导的迁移/侵袭。条件性c-Kit等位基因的激活在DLD-1 CRC细胞中诱导了几种干性标志物。在原发性CRC样本中,c-Kit表达升高也与干性标志物(如Lgr5、CD44、OLFM4、BMI-1和β-连环蛋白)呈正相关。相反,在DLD-1细胞中条件性miR-34a等位基因的激活降低了c-Kit和几种干性标志物(CD44、Lgr5和BMI-1)的表达,并抑制了球体形成。miR-34a还抑制了暴露于SCF后增强的球体形成。综上所述,我们的数据确定c-Kit为miR-34的新直接靶点,并证明这种调节干扰了几种c-Kit介导的对癌细胞的作用。因此,这种调节可能与未来的诊断和治疗方法潜在相关。